There is no fixed amount that HbA1c should drop in three months. It may fall a little or by more than one percentage point when average blood sugar improves substantially, especially after an effective treatment change. The size of the drop depends on the starting result, the treatment used, and how well it works over time. A repeat test helps show the overall response.
What is a realistic HbA1c drop in three months?
The amount HbA1c can decrease over three months varies considerably. A person whose blood sugar improves only slightly may see a small change, while someone who experiences a substantial improvement after starting or adjusting effective diabetes treatment may see a larger reduction.
For adults with type 2 diabetes, the American Diabetes Association's 2026 Standards of Care reports that adding a new class of oral, non-insulin diabetes medicine to metformin generally lowers HbA1c by about 0.7–1.0 percentage points. Adding a glucagon-like peptide-1 (GLP-1) receptor agonist or a dual GIP/GLP-1 receptor agonist to metformin often lowers it by about 1 percentage point to 2 or more percentage points. These are study-based averages for particular treatment changes, not guaranteed results or limits on what an individual may experience.
A percentage-point decrease is the difference between two HbA1c percentages. It is not the same as a percentage reduction relative to the starting result. When comparing test results, it is therefore important to consider the actual difference between them, as well as the person's glucose readings and treatment goals.
Why is three months an important timeframe?
HbA1c measures the percentage of hemoglobin, the oxygen-carrying protein in red blood cells, that has glucose attached to it. Because red blood cells circulate for several months, the result provides an estimate of average blood sugar over roughly the previous two to three months rather than showing the level on a single day.
The Centers for Disease Control and Prevention (CDC) explains that HbA1c is used both to assess blood sugar over time and to monitor diabetes management. This makes a three-month interval useful for reviewing whether changes to a treatment plan have helped. However, the test does not give equal weight to every day in that period; recent blood sugar levels influence the result more than earlier levels.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) notes that substantial changes in blood glucose during the most recent month can have a noticeable effect on HbA1c. This means improvement can begin to appear before three full months have passed, although an early result may not reflect the full effect of a longer-term treatment plan.
What determines how much HbA1c falls?
The starting HbA1c level
The starting result is an important part of the picture. When average blood sugar is substantially above the person's treatment goal, there may be more room for improvement. If blood sugar is already close to the agreed target, a smaller decrease may be expected or appropriate. A small change does not automatically mean that a treatment plan has failed, just as a large change does not by itself prove that the final result is suitable for that person.
Changes to diabetes treatment
The effect of treatment depends on which medicines are used, their glucose-lowering effectiveness, and whether the plan is suitable for the person. Starting a medicine, changing a dose under medical supervision, or adding another medicine may produce a different HbA1c response from continuing an unchanged plan. Insulin and other medicines also differ in their effects and risks, so the goal is not simply to make the result fall as quickly as possible.
Do not increase, reduce, or stop prescribed diabetes medicines on your own to try to achieve a larger decrease. Some treatments can cause blood sugar to fall too low, and medication adjustments should take account of glucose readings, side effects, other health conditions, and the person's agreed treatment goal.
Everyday habits and consistency
Food choices, regular physical activity, and following an agreed treatment plan can all contribute to better blood sugar management. The effect of these changes depends on the person's circumstances and how much their average glucose improves. There is no single diet, exercise routine, or number of lifestyle changes that guarantees a particular HbA1c reduction within three months.
Consistency matters because HbA1c reflects glucose exposure over time. Repeated periods of higher blood sugar can influence the average even when some readings are within the desired range. Home glucose monitoring or continuous glucose monitoring, when recommended, can help show patterns that an HbA1c test alone may not reveal.
Illness, missed treatment, and other influences
Illness, stress, changes in eating or activity patterns, and missed doses can affect blood glucose management. These influences may help explain why an HbA1c result changes less than expected. If the result remains above the agreed target, a healthcare professional can review glucose records, how the treatment plan is being followed, and whether adjustments are needed.
What if HbA1c has barely changed after three months?
A small decrease, no apparent change, or an increase can have several explanations. Average glucose may not have improved enough to produce a larger difference, the treatment may need reassessment, or day-to-day glucose patterns may still include periods of higher readings. The result should be considered alongside home measurements or continuous glucose monitoring when available.
Sometimes the HbA1c result does not match other glucose measurements. The NIDDK explains that conditions affecting red blood cells or hemoglobin can make HbA1c less reliable. Examples include iron-deficiency anemia, recent blood loss or transfusion, certain hemoglobin variants, and some cases of kidney or liver disease. If a result seems inconsistent with other measurements, the healthcare professional may investigate the difference or consider another way to assess glucose control.
Do not judge progress from the size of the drop alone. The starting result, current result, glucose patterns, treatment effects, and personal health circumstances all matter. If HbA1c has not improved as expected, a review of the treatment plan is more useful than trying to force a faster reduction without supervision.
When should HbA1c be checked again?
For adults with type 2 diabetes, the National Institute for Health and Care Excellence (NICE) recommends measuring HbA1c every three to six months until the result is stable on an unchanged treatment plan. Once blood glucose management and treatment are stable, testing every six months may be appropriate. The timing should be tailored to the person's needs and clinical situation.
A three-month test is particularly useful after changes to treatment or when the agreed glucose goals have not yet been reached. Results can help the healthcare professional decide whether the current plan is working, whether it needs adjustment, or whether a test-related factor could be affecting interpretation.
Does a lower HbA1c always mean better control?
A lower HbA1c can reflect improved average blood sugar, but the lowest possible result is not the right goal for everyone. Treatment targets are individualized according to factors such as age, overall health, other medical conditions, and the risk of low blood sugar.
The American Diabetes Association explains that the HbA1c target for many people with diabetes is 7% or less, but an appropriate target may be higher or lower depending on individual circumstances. A healthcare professional can help determine whether the change over three months is beneficial and whether the treatment plan remains safe. The aim is sustainable glucose management, not achieving the biggest possible drop in isolation.